0 Avaliações
ID

13240

Descrição

Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG; ODM derived from: https://clinicaltrials.gov/show/NCT00061425

Link

https://clinicaltrials.gov/show/NCT00061425

Palavras-chave

Versões (1)
  1. 25/01/2016 25/01/2016 -
Transferido a

25 de janeiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    Inglês

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    1 Formulários  
    Criteria
    Descrição

    Criteria

    histological or cytological diagnosis of b-cell lymphoma, and has failed at least one regimen of standard chemotherapy. (all histological grades of nhl will be eligible for this trial.)
    Descrição

    b-cell lymphoma, chemotherapy

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0079731
    UMLS CUI [2]
    C0392920
    measureable via ct, with at least one lesion > or = 1.5cm in one or both dimensions. (splenic tumors in absence of other tumors will not qualify.)
    Descrição

    measureable

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    radiological studies (ie - ct) must be performed within 4 weeks prior to study start.
    Descrição

    radiologic exam

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C2985535
    acceptable tumor burden that will allow adequate follow-up and evaluation.
    Descrição

    follow-up, evaluation

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1522577
    UMLS CUI [2]
    C0220825
    less that 25% bone marrow involvement, determined by bone marrow biopsy.
    Descrição

    bone marrow

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0005953
    at least 4 weeks beyond any major surgery. at least 4 weeks beyond any radiation therapy to the index lesion, and has recovered from radiation-induced toxicity.
    Descrição

    major surgery, radiation therapy

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2]
    C1522449
    at least 4 weeks beyond chemotherapy and/or immunotherapy. at least 2 weeks beyond corticosteriod(s) use and blood counts are with laboratory criteria.
    Descrição

    chemotherapy, immunotherapy, corticosteroids

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C0021083
    UMLS CUI [3]
    C0001617
    must have karnofsky score >70% (or equivalent, ecog 0-2) with expected survival of at least 6 months.
    Descrição

    karnofsky

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    serum creatinine < or = 1.5mg/dl or creatinine clearance > or = 50ml/min.
    Descrição

    creatinine, creatinine clearance

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C0373595
    serum bilirubin < or = 2mg/dl.
    Descrição

    bilirubin

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    hemoglobin > or = 10 g/dl; wbc > or = 3000/mm3; granulocyte count > or = 150/mm3; platelet count > or = 100,000/mm3 with out transfusions or cytokines for at least 30 days prior to study.
    Descrição

    hemoglobin, granulocyte count, transfusions, cytokines

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0518015
    UMLS CUI [2]
    C0857490
    UMLS CUI [3]
    C0032181
    UMLS CUI [4]
    C1879316
    UMLS CUI [5]
    C0199974
    immunomedics elisa assay of hahll2 < 100ng/ml for those with prior history of monoclonal antibody infusions.
    Descrição

    human anti-human antibodies

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C3641682
    cognizant informed consent.
    Descrição

    informed consent

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Voltar ao início da página

    Similar models

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    1 Formulários
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    b-cell lymphoma, chemotherapy
    Item
    histological or cytological diagnosis of b-cell lymphoma, and has failed at least one regimen of standard chemotherapy. (all histological grades of nhl will be eligible for this trial.)
    boolean
    C0079731 (UMLS CUI [1])
    C0392920 (UMLS CUI [2])
    measureable
    Item
    measureable via ct, with at least one lesion > or = 1.5cm in one or both dimensions. (splenic tumors in absence of other tumors will not qualify.)
    boolean
    C1513041 (UMLS CUI [1])
    radiologic exam
    Item
    radiological studies (ie - ct) must be performed within 4 weeks prior to study start.
    boolean
    C2985535 (UMLS CUI [1])
    follow-up, evaluation
    Item
    acceptable tumor burden that will allow adequate follow-up and evaluation.
    boolean
    C1522577 (UMLS CUI [1])
    C0220825 (UMLS CUI [2])
    bone marrow
    Item
    less that 25% bone marrow involvement, determined by bone marrow biopsy.
    boolean
    C0005953 (UMLS CUI [1])
    major surgery, radiation therapy
    Item
    at least 4 weeks beyond any major surgery. at least 4 weeks beyond any radiation therapy to the index lesion, and has recovered from radiation-induced toxicity.
    boolean
    C0679637 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    chemotherapy, immunotherapy, corticosteroids
    Item
    at least 4 weeks beyond chemotherapy and/or immunotherapy. at least 2 weeks beyond corticosteriod(s) use and blood counts are with laboratory criteria.
    boolean
    C0392920 (UMLS CUI [1])
    C0021083 (UMLS CUI [2])
    C0001617 (UMLS CUI [3])
    karnofsky
    Item
    must have karnofsky score >70% (or equivalent, ecog 0-2) with expected survival of at least 6 months.
    boolean
    C0206065 (UMLS CUI [1])
    creatinine, creatinine clearance
    Item
    serum creatinine < or = 1.5mg/dl or creatinine clearance > or = 50ml/min.
    boolean
    C0201976 (UMLS CUI [1])
    C0373595 (UMLS CUI [2])
    bilirubin
    Item
    serum bilirubin < or = 2mg/dl.
    boolean
    C1278039 (UMLS CUI [1])
    hemoglobin, granulocyte count, transfusions, cytokines
    Item
    hemoglobin > or = 10 g/dl; wbc > or = 3000/mm3; granulocyte count > or = 150/mm3; platelet count > or = 100,000/mm3 with out transfusions or cytokines for at least 30 days prior to study.
    boolean
    C0518015 (UMLS CUI [1])
    C0857490 (UMLS CUI [2])
    C0032181 (UMLS CUI [3])
    C1879316 (UMLS CUI [4])
    C0199974 (UMLS CUI [5])
    human anti-human antibodies
    Item
    immunomedics elisa assay of hahll2 < 100ng/ml for those with prior history of monoclonal antibody infusions.
    boolean
    C3641682 (UMLS CUI [1])
    informed consent
    Item
    cognizant informed consent.
    boolean
    C0021430 (UMLS CUI [1])
    Voltar ao início da página 

    Ajuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial